Sale!

RPGRIP1 Gene Cone-Rod Dystrophy Type 13 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The RPGRIP1 Gene Cone-Rod Dystrophy Type 13 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the RPGRIP1 gene responsible for cone-rod dystrophy type 13, a progressive inherited retinal disorder. This comprehensive test utilizes next-generation sequencing technology to provide accurate detection of genetic variants associated with vision loss. Patients experiencing night blindness, photophobia, color vision abnormalities, or progressive central vision loss should consider this test. Early diagnosis enables proactive management strategies and genetic counseling for family planning. The test costs $500 USD and provides results within 3-4 weeks using blood, extracted DNA, or FTA card samples. Genetic counseling is recommended before testing to understand familial inheritance patterns.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

RPGRIP1 Gene Cone-Rod Dystrophy Type 13 NGS Genetic DNA Test

Comprehensive Genetic Testing for Inherited Retinal Disorders

The RPGRIP1 Gene Cone-Rod Dystrophy Type 13 NGS Genetic DNA Test represents a breakthrough in ophthalmic genetic diagnostics, offering precise detection of mutations responsible for this progressive retinal condition. Cone-rod dystrophy type 13 is an inherited eye disorder characterized by the degeneration of cone and rod photoreceptor cells, leading to progressive vision impairment that typically begins in childhood or early adulthood.

What This Advanced Genetic Test Detects

This sophisticated diagnostic tool specifically targets mutations in the RPGRIP1 (Retinitis Pigmentosa GTPase Regulator Interacting Protein 1) gene, which plays a crucial role in maintaining the structural integrity of photoreceptor cells in the retina. The test utilizes next-generation sequencing (NGS) technology to comprehensively analyze the entire RPGRIP1 gene, identifying:

  • Point mutations and single nucleotide variants
  • Small insertions and deletions
  • Copy number variations
  • Pathogenic variants affecting protein function
  • Autosomal recessive inheritance patterns

Who Should Consider RPGRIP1 Genetic Testing?

This test is particularly recommended for individuals experiencing symptoms suggestive of cone-rod dystrophy or those with a family history of inherited retinal disorders. Key indicators include:

  • Progressive vision loss beginning in childhood or early adulthood
  • Difficulty with night vision (nyctalopia)
  • Sensitivity to bright light (photophobia)
  • Color vision abnormalities
  • Loss of central vision affecting reading and facial recognition
  • Peripheral vision deterioration
  • Family history of similar visual symptoms
  • Abnormal electroretinogram (ERG) results

Significant Benefits of Early Genetic Diagnosis

Obtaining a precise genetic diagnosis through RPGRIP1 testing provides numerous advantages for patients and their families:

  • Accurate Diagnosis: Confirms the specific genetic cause of vision symptoms
  • Prognostic Information: Helps predict disease progression and severity
  • Family Planning: Enables informed reproductive decisions and genetic counseling
  • Clinical Management: Guides appropriate monitoring and intervention strategies
  • Research Opportunities: Connects patients with clinical trials and emerging therapies
  • Psychological Relief: Provides clarity and reduces diagnostic uncertainty

Understanding Your Test Results

Our comprehensive genetic counseling services help patients interpret their RPGRIP1 test results effectively:

  • Positive Result: Indicates the presence of pathogenic mutations in both copies of the RPGRIP1 gene, confirming cone-rod dystrophy type 13 diagnosis
  • Negative Result: No disease-causing mutations detected in the RPGRIP1 gene, though other genetic causes may need investigation
  • Variant of Uncertain Significance: Identifies genetic changes with unclear clinical implications requiring further evaluation
  • Carrier Status: Detection of a single mutated copy, indicating carrier status without disease manifestation

Test Pricing and Sample Requirements

Test Component Details
Test Name RPGRIP1 Gene Cone-Rod Dystrophy Type 13 NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Types Blood, Extracted DNA, or One Drop Blood on FTA Card

Pre-Test Preparation and Requirements

To ensure optimal testing outcomes, we recommend:

  • Comprehensive clinical history documentation
  • Genetic counseling session before testing
  • Development of detailed family pedigree chart
  • Ophthalmological examination records
  • Discussion of testing implications and potential outcomes

Nationwide Accessibility and Expert Support

GGC DNA maintains testing facilities across major metropolitan areas throughout the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and ophthalmology specialists ensures comprehensive patient support throughout the testing process.

Take Control of Your Vision Health Today

Don’t let uncertainty about your vision symptoms continue. Early genetic diagnosis can provide clarity, guide appropriate management, and connect you with valuable resources. Our dedicated team is ready to assist you with scheduling, insurance questions, and result interpretation.

Call or WhatsApp us today at +1(267) 388-9828 to book your RPGRIP1 genetic test and take the first step toward understanding your vision health.